- Citado por SciELO
- Citado por Google
- Similares en SciELO
- Similares en Google
Journal of the Chilean Chemical Society
versión On-line ISSN 0717-9707
NAVANEETHAN, G; KARUNAKARAN, K y ELANGO, K. P. SIMULTANEOUS ESTIMATION OF PIOGLITAZONE, GLIMEPIRIDE AND GLIMEPIRIDE IMPURITIES IN COMBINATION DRUG PRODUCT BY A VALIDATED STABILITY- INDICATING RP-HPLC METHOD. J. Chil. Chem. Soc. [online]. 2011, vol.56, n.3, pp.815-818. ISSN 0717-9707. http://dx.doi.org/10.4067/S0717-97072011000300021.
A new, single, stability indicating RP-HPLC method has been developed and validated for the simultaneous estimation of pioglitazone, glimepiride and glimepiride impurities i.e., related compound B and related compound C from combination drug product containing pioglitazone, glimepiride and metformin HCl. The chromatographic separation was achieved on a cyano stationary phase (250 x 4.6mm, 5.0 microns particles) with simple mobile phase combination delivered in gradient mode at a flow rate of 0.8mL min1 at 230nm. In the developed method, the critical close eluting compound of glimepiride related compound B and related compound C was found more than 6.5 resolutions. This method is capable to detect glimepiride related compound B and related compound C at a level below 0.005% with respect to glimepiride sample concentration of 0.1mg mL-1 for a 25 µL injection volume. The proposed method was validated according to the ICH guidelines and proved suitable for routine and stability analysis of these drugs in pharmaceutical preparations.
Palabras clave : stability indicating; peak purity; impurities; validation.